Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Phagenix

France 60 Avenue Rockefeller, 69008 Lyon, France

About the sponsor

Phagenix concentrates on therapeutic strategies for bacterial urinary infection, addressing both acute and recurrent cases.

  • Targeted antimicrobial agents against Escherichia coli
  • Novel oral therapies for urinary tract infection
  • Mechanisms of antibiotic resistance in uropathogens

Research includes pharmacokinetic optimization and safety profiling for agents intended for the urinary tract.

About Specializations

Phagenix runs clinical trials in conditions such as Staphylococcal infection, Medical device site joint infection, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Staphylococcal infection+1

Not yet recruiting

Study of PP1493 and PP1815 phage therapy for patients with knee or hip joint infections caused by Staphylococcus aureus after prosthetic surgery

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Phagenix

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.